10x Genomics, Inc. Class A Common Stock
A$34.35
AUD
Last updated on --.
24h volume1.97M
24h highest34.8471 AUD
24h lowest32.1269 AUD
24h Price movement+4.01%
TXG recent prices
24 Hours
+4.01%+A$1.325
30 days
+10.14%+A$3.152
60 days
+21.56%+A$5.859
90 days
+10.89%+A$3.361
Key data
Previous close33.0336 AUD
Market cap4.25B AUD
Volume1.97M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.25110 AUD
Net income (FY)-31.61M AUD
Revenue (FY)891.10M AUD
Last report date8 May 2026
About 10x Genomics, Inc. Class A Common Stock
HeadquartersPLEASANTON
Employees (FY)1.18K
Revenue per employee (FY)756.45K AUD
Net income per employee (FY)-26.83K AUD
Listed onNasdaq
TXG conversion tables
 |  |
|---|---|
| 0.5 TXG | 17.17 AUD |
| 1 TXG | 34.35 AUD |
| 5 TXG | 171.79 AUD |
| 10 TXG | 343.58 AUD |
| |
|---|---|
| 0.5 AUD | 0.014552 TXG |
| 1 AUD | 0.029105 TXG |
| 5 AUD | 0.14552 TXG |
| 10 AUD | 0.29105 TXG |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
TXG is trading at A$34.35, +4.01% over the last 24 hours. Track live moves on the price chart at the top of this page.
The TXG stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. TXG is currently trading at A$34.35, +4.01% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on TXG price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the LABORATORY ANALYTICAL INSTRUMENTS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. TXG's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from TXG; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against TXG's historical range and other companies in the LABORATORY ANALYTICAL INSTRUMENTS sector.
10x Genomics, Inc. Class A Common Stock's market cap is currently 4.25B AUD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume1.97M
24h highest34.8471 AUD
24h lowest32.1269 AUD
24h Price movement+4.01%
Start trade with TXG Perpetual
Sign up to trade